Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $56.8200 (-0.54%) ($56.8200 - $56.8200) on Wed. Dec. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.2% (three month average) | RSI | 46 | Latest Price | $56.8200(-0.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(36%) IFRA(33%) IWO(32%) IWM(31%) IWN(29%) | Factors Impacting HALO price | HALO will decline at least -1.1% in a week (0% probabilities). XBI(-13%) VIXM(-10%) IGOV(-10%) EDOC(-10%) GLD(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.1% (StdDev 2.2%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $57.39 | 5 Day Moving Average | $57.53(-1.23%) | 10 Day Moving Average | $57.25(-0.75%) | 20 Day Moving Average | $57.39(-0.99%) | To recent high | -4.2% | To recent low | 43.8% | Market Cap | $7.766b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |